Literature DB >> 13042796

Growth characteristics of free C1498 granulocytic leukemia tumor cells in the peritoneal fluid and the blood of C57 mice.

H GOLDIE, C H BUTLER, M M ANDERSON, M C MAXWELL, P F HAHN.   

Abstract

Entities:  

Keywords:  LEUKEMIA/experimental

Mesh：

Year:  1953        PMID： 13042796

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  New approach to therapy of malignant disease: prevention of metastatic growth.

Authors:  M WALKER; H GOLDIE
Journal:  J Natl Med Assoc       Date:  1962-01       Impact factor: 1.798

2.  Assay of chemical and radioactive agents for inhibition of local (topical) and systemic (metastatic) tumor cell spread in the mouse.

Authors:  H GOLDIE; M WALKER
Journal:  J Natl Med Assoc       Date:  1962-01       Impact factor: 1.798

3.  [Some recent studies on the production and growth characteristics of ascites tumors; a review].

Authors:  G KLEIN
Journal:  Z Krebsforsch       Date:  1956

4.  Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia.

Authors:  Kazutoshi Fujita; Hiroshi Ohta; Akira Tsujimura; Tetsuya Takao; Yasushi Miyagawa; Shingo Takada; Kiyomi Matsumiya; Teruhiko Wakayama; Akihiko Okuyama
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

5.  SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells.

Authors:  Robert Brooks; Gwenny M Fuhler; Sonia Iyer; Michelle J Smith; Mi-Young Park; Kim H T Paraiso; Robert W Engelman; William G Kerr
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

6.  Utilization of interleukin-2 gene transfer in local immunotherapy of cancer.

Authors:  J Bubeník; J Símová; D Bubeníková; J Zeuthen; C Radzikowski
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

7.  A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model.

Authors:  Alexia Mopin; Virginie Driss; Carine Brinster
Journal:  J Vis Exp       Date:  2016-10-14       Impact factor: 1.355

8.  Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemia.

Authors:  Xiufen Chen; Dominick Fosco; Douglas E Kline; Justin Kline
Journal:  Oncoimmunology       Date:  2017-01-10       Impact factor: 8.110
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.